Lobbying client

CIPLA USA, INC.

Pharmaceutical Manufacturing

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
12
Filed by
2
Reported in-house
—
Reported by firms
$300,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2015 to 2020

Filings

12 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination (No Activity)
2nd Quarter 2020
D.L. GARDNER AND ASSOCIATES — reported
1st Quarter - Termination
1st Quarter 2020
D.L. GARDNER AND ASSOCIATES $12,500 reported
1st Quarter - Reportreplaced
1st Quarter 2020
D.L. GARDNER AND ASSOCIATES $12,500 reported
4th Quarter - Report
4th Quarter 2019
D.L. GARDNER AND ASSOCIATES $37,500 reported
3rd Quarter - Amendment
3rd Quarter 2019
D.L. GARDNER AND ASSOCIATES $25,000 reported
Registration
3rd Quarter 2019
D.L. GARDNER AND ASSOCIATES — reported
1st Quarter - Termination
1st Quarter 2016
RUBICON ADVISORS, LLC $45,000 reported
4th Quarter - Report
4th Quarter 2015
RUBICON ADVISORS, LLC $45,000 reported
3rd Quarter - Report
3rd Quarter 2015
RUBICON ADVISORS, LLC $45,000 reported
2nd Quarter - Report
2nd Quarter 2015
RUBICON ADVISORS, LLC $45,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
RUBICON ADVISORS, LLC 5 $225,000
D.L. GARDNER AND ASSOCIATES 4 $75,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Pharmacy PHA 6
Health Issues HCR 4
Medical/Disease Research/Clinical Labs MED 4

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.